AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

In this interview, rare disease expert Oxana Iliach discusses challenges with rare disease drug development and how they can ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

We talk to Xinyue Chen about her project look at the role of methylation in memory consolidation during sleep.

Using the Ultima Genomics’ (CA, USA) lower-cost WGS platform and the known mutational patterns in patient tumors as a guide, ...

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

Introducing our In Focus on organ-on-a-chip (OoC) technology in drug development, this video explores what OoCs are, how they ...

Drug development is a notoriously slow, complex and costly process, with over 90% of drug candidates failing before reaching the market. A major cause of this inefficiency is the reliance on ...

A new set of genes that contribute to Parkinson’s disease risk has been identified. Why is it that some individuals with Parkinson’s disease (PD)-associated genetic variants develop the disease, while ...

The US FDA recently announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs, replacing it with more effective, human-relevant methods, such as ...

The Center for Predictive in vitro Models (CPM) at Queen Mary University of London (QMUL; UK) brings together over 100 academic staff and post docs who specialize in developing and using ...